Related Experiment Videos
Disease management programme for diabetes mellitus in Nepal
JNMA; Journal of the Nepal Medical Association
|November 26, 2010
Summary
Diabetes prevalence in Nepal is rising, projected to reach 17.49% by 2020. Implementing a diabetes disease management program can reduce healthcare costs and hospital stays.
Area of Science:
- Public Health
- Epidemiology
- Health Services Research
Background:
- The prevalence of diabetes mellitus (DM) is increasing globally, particularly among the elderly.
- Patients' rising awareness of their condition and available technology necessitates innovative healthcare services.
- Disease Management Programmes (DMPs) offer a structured, evidence-based approach to managing chronic diseases like DM, improving outcomes and reducing costs.
Purpose of the Study:
- To project the future prevalence of diagnosed diabetes mellitus in Nepal.
- To evaluate the impact of a diabetes disease management programme on healthcare costs and hospital stay.
Main Methods:
- Utilized authenticated hospital-based data from urban and rural settings in Nepal.
- Employed IDL mathematical software for best-fit regression analysis to project DM prevalence.
- Conducted a review of existing literature on DM prevalence and DMPs.
Main Results:
- Projected diagnosed DM prevalence in Nepal to be 12.73% (2010), 15.11% (2015), and 17.49% (2020).
- Demonstrated that a diabetes disease management programme effectively reduces healthcare costs and hospitalizations.
Conclusions:
- Without intervention, the number of new diabetes cases in Nepal is expected to rise annually.
- There is a critical need for implementing effective diabetes disease management programmes nationwide.
- Addressing increased patient awareness requires the development and integration of innovative healthcare services.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...